From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Outcome | JIA <18 years n=7883 | JIA ≥18 years n=4867 | RA ≥18 years n=286,601 |
---|---|---|---|
Uveitis | 4.44 (3.99, 4.89) | 1.50 (1.16, 1.84) | 0.52 (0.49, 0.55) |
SLE | 1.13 (0.90, 1.36) | 3.10 (2.62, 3.59) | 3.78 (3.71, 3.85) |
Type 1 diabetes mellitus | 0.79 (0.59, 0.98) | 1.87 (1.49, 2.25) | 1.83 (1.78, 1.88) |
Chronic urticaria | 1.74 (1.45, 2.03) | 1.71 (1.34, 2.07) | 0.71 (0.67, 0.74) |
Ankylosing spondylitis | 1.67 (1.39, 1.96) | 1.48 (1.14, 1.82) | 1.16 (1.12, 1.20) |
Crohn’s disease | 1.18 (0.94, 1.42) | 1.62 (1.27, 1.98) | 1.12 (1.08, 1.16) |
Ulcerative colitis | 0.44 (0.30, 0.59) | 1.36 (1.03, 1.68) | 0.87 (0.83, 0.90) |
Sjögren’s syndrome | 0.15 (0.07, 0.24) | 1.29 (0.98, 1.61) | 2.42 (2.36, 2.48) |
Raynaud’s syndrome | 0.63 (0.46, 0.81) | 1.23 (0.92, 1.54) | 1.12 (1.09, 1.16) |